{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:49:26Z","timestamp":1776412166017,"version":"3.51.2"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2K24AI125685"],"award-info":[{"award-number":["2K24AI125685"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chlamydia infection remains a global health concern, justifying the need for a chlamydia vaccine. Chlamydia infection rates are highest among young women and men; thus, they would be the target populations for vaccination. However, vaccine availability does not ensure uptake. We conducted a survey among youth to identify factors that may influence chlamydia vaccine acceptability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Females and males aged 16\u201329 years seen for care in adolescent, gynecology, student health, and sexual health clinics completed a computer-assisted survey, collecting information on sexual health, health care utilization, vaccination history, and factors related to chlamydia and vaccine acceptability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 399 female and 221 male participants, most (93.2%) had heard of chlamydia, 28.1% reported prior chlamydia infection, and 52.6% believed they could acquire chlamydia infection. Interest in chlamydia vaccination was reported by 42.4% females and associated with non-Black race, Hispanic ethnicity, clinic site, previous influenza or COVID-19 vaccination, and awareness of human papillomavirus vaccination. Among males, 44.8% reported chlamydia vaccination interest that was associated with ethnicity, human papillomavirus vaccine awareness, chlamydia awareness, prior chlamydia infection, and possibility of acquiring chlamydia infection. Among all participants, most (82.5%) reported their main motivation for vaccination was to protect themselves and major barriers were concerns about safety (50.0%) and cost (23.1%). The majority (66.0%) reported health care providers as the main resource for vaccine information and were more likely to get vaccinated if recommended by them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Less than half of surveyed youth were interested in receiving a chlamydia vaccine. Findings will guide strategies for chlamydia vaccine implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag166","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:54:07Z","timestamp":1773838447000},"source":"Crossref","is-referenced-by-count":0,"title":["Acceptability of a Chlamydia Vaccine Among Young Women and Men in Birmingham, Alabama, USA: 2023\u20132025"],"prefix":"10.1093","volume":"13","author":[{"given":"Kanupriya","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Medicine; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bria I","family":"Gamble","sequence":"additional","affiliation":[{"name":"Heersink School of Medicine; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison J","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamuktha","family":"Pentala","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J","family":"Shiry","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9285-7321","authenticated-orcid":false,"given":"Kristal J","family":"Aaron","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janeen L","family":"Arbuckle","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-9329","authenticated-orcid":false,"given":"Samantha V","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3064-8564","authenticated-orcid":false,"given":"Barbara","family":"Van Der Pol","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0603-2404","authenticated-orcid":false,"given":"William M","family":"Geisler","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2026041703020713100_ofag166-B1","volume-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030","author":"World Health Organization","year":"2022"},{"key":"2026041703020713100_ofag166-B2","volume-title":"Sexually transmitted disease surveillance 2023","author":"Centers for Disease Control and Prevention","year":"2024"},{"issue":"RR-04","key":"2026041703020713100_ofag166-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted diseases treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2026041703020713100_ofag166-B4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/OLQ.0b013e3181a2a933","article-title":"Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature","volume":"36","author":"Hosenfeld","year":"2009","journal-title":"Sex Transm Dis"},{"key":"2026041703020713100_ofag166-B5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/sti.2006.024059","article-title":"Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting","volume":"83","author":"Fung","year":"2007","journal-title":"Sex Transm Infect"},{"key":"2026041703020713100_ofag166-B6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/OLQ.0b013e31815e41a3","article-title":"The arrested immunity hypothesis and the epidemiology of chlamydia control","volume":"35","author":"Brunham","year":"2008","journal-title":"Sex Transm Dis"},{"key":"2026041703020713100_ofag166-B7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.15698\/mic2016.09.525","article-title":"Chlamydia trachomatis genital infections","volume":"3","author":"O'Connell","year":"2016","journal-title":"Microb Cell"},{"key":"2026041703020713100_ofag166-B8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026041703020713100_ofag166-B9","first-page":"54","article-title":"Progress towards effective vaccines for Chlamydia trachomatis","volume":"38","author":"Collar","year":"2025","journal-title":"Curr Opin Infect Dis"},{"key":"2026041703020713100_ofag166-B10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1473-3099(24)00147-6","article-title":"An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial","volume":"24","author":"Pollock","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026041703020713100_ofag166-B11","doi-asserted-by":"crossref","first-page":"e1544","DOI":"10.1016\/S2214-109X(24)00266-3","article-title":"WHO global research priorities for sexually transmitted infections","volume":"12","author":"Gottlieb","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026041703020713100_ofag166-B12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOP.0000000000001441","article-title":"HPV vaccine hesitancy in the United States","volume":"37","author":"Joshi","year":"2025","journal-title":"Curr Opin Pediatr"},{"key":"2026041703020713100_ofag166-B13","doi-asserted-by":"crossref","first-page":"e072619","DOI":"10.1136\/bmjopen-2023-072619","article-title":"They've all endorsed it\u2026but I'm just not there:\u2019 a qualitative exploration of COVID-19 vaccine hesitancy reported by Black and Latinx individuals","volume":"13","author":"Scales","year":"2023","journal-title":"BMJ Open"},{"key":"2026041703020713100_ofag166-B14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jval.2022.07.019","article-title":"Preferences for sexually transmitted infection and cancer vaccines in the United States and in China","volume":"26","author":"Wagner","year":"2023","journal-title":"Value Health"},{"key":"2026041703020713100_ofag166-B15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s10900-023-01205-9","article-title":"Parent-reported barriers and parental beliefs associated with intentions to obtain HPV vaccination for children in a primary care patient population in Minnesota, USA","volume":"48","author":"Zhu","year":"2023","journal-title":"J Community Health"},{"key":"2026041703020713100_ofag166-B16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMp2100351","article-title":"An uncertain public - encouraging acceptance of COVID-19 vaccines","volume":"384","author":"SteelFisher","year":"2021","journal-title":"N Engl J Med"},{"key":"2026041703020713100_ofag166-B17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00007435-200001000-00010","article-title":"Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control","volume":"27","author":"Zimet","year":"2000","journal-title":"Sex Transm Dis"},{"key":"2026041703020713100_ofag166-B18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1186\/s12913-023-10334-9","article-title":"Public willingness to receive chlamydia, gonorrhea, syphilis, and trichomoniasis vaccines: a scoping review","volume":"23","author":"Valleroy","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"2026041703020713100_ofag166-B19","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1016\/j.vaccine.2023.08.044","article-title":"The impact of the COVID-19 pandemic on parental vaccine hesitancy: a cross-sectional survey","volume":"41","author":"Grills","year":"2023","journal-title":"Vaccine"},{"key":"2026041703020713100_ofag166-B20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.17269\/s41997-022-00648-2","article-title":"Factors associated with intention to receive vaccines for bacterial sexually transmitted infections among young HPV-vaccinated Canadian women","volume":"113","author":"de Waal","year":"2022","journal-title":"Can J Public Health"},{"key":"2026041703020713100_ofag166-B21","first-page":"A162","article-title":"Factors associated with interest in bacterial sexually transmitted infection vaccines among young HPV-vaccinated Canadian women","volume":"97","author":"de Waal","year":"2021","journal-title":"Sex Transm Infect"},{"key":"2026041703020713100_ofag166-B22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/sextrans-2019-054311","article-title":"Factors associated with interest in bacterial sexually transmitted infection vaccines at two large sexually transmitted infection clinics in British Columbia, Canada","volume":"96","author":"Plotnikoff","year":"2020","journal-title":"Sex Transm Infect"},{"key":"2026041703020713100_ofag166-B23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jadohealth.2023.01.021","article-title":"The future of sexually transmitted infection research: understanding adolescent perspectives for implementation of a chlamydia vaccine","volume":"73","author":"Recto","year":"2023","journal-title":"J Adolesc Health"},{"key":"2026041703020713100_ofag166-B24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/MLR.0b013e31817a835d","article-title":"National health surveys and the behavioral model of health services use","volume":"46","author":"Andersen","year":"2008","journal-title":"Med Care"},{"key":"2026041703020713100_ofag166-B25","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/OLQ.0000000000001663","article-title":"Perceived need and acceptance of a future chlamydia vaccine among health care providers","volume":"49","author":"Footman","year":"2022","journal-title":"Sex Transm Dis"},{"key":"2026041703020713100_ofag166-B26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/OLQ.0000000000001692","article-title":"Chlamydia vaccination: parent opinions and implications for future promotion programs","volume":"49","author":"Footman","year":"2022","journal-title":"Sex Transm Dis"},{"key":"2026041703020713100_ofag166-B27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41591-024-02939-2","article-title":"Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023","volume":"30","author":"Lazarus","year":"2024","journal-title":"Nat Med"},{"key":"2026041703020713100_ofag166-B28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jadohealth.2016.01.002","article-title":"Sexually transmitted infection testing among adolescents and young adults in the United States","volume":"58","author":"Cuffe","year":"2016","journal-title":"J Adolescent Health"},{"key":"2026041703020713100_ofag166-B29","first-page":"S87","article-title":"Assessing the quality of physician communication about human papillomavirus vaccine: findings from a national survey","volume":"49","author":"Gilkey","year":"2015","journal-title":"Ann Behav Med"},{"key":"2026041703020713100_ofag166-B30","first-page":"S203","article-title":"Adolescent perspectives on acceptance of a chlamydia vaccine and willingness to participate in vaccine-related research","volume":"43","author":"Trent","year":"2016","journal-title":"Sex Transm Dis"},{"key":"2026041703020713100_ofag166-B31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s43856-022-00123-6","article-title":"Assessing the impact of novelty and conformity on hesitancy towards COVID-19 vaccines using mRNA technology","volume":"2","author":"Leong","year":"2022","journal-title":"Commun Med (Lond)"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag166\/67417519\/ofag166.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/4\/ofag166\/68099288\/ofag166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/4\/ofag166\/68099288\/ofag166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:02:35Z","timestamp":1776409355000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag166\/8529284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag166","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,19]]},"article-number":"ofag166"}}